COMMUNIQUÉS West-GlobeNewswire

-
SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA® (pembrolizumab) Program with Dosing of First Patient in Phase 1/2 Basket Study
31/07/2019 -
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
31/07/2019 -
Catalyst Pharmaceuticals to Hold Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 8th, 2019
31/07/2019 -
Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
31/07/2019 -
Align Technology Announces $200 Million Accelerated Stock Repurchase Program
31/07/2019 -
Jounce Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 7, 2019
31/07/2019 -
Intercept to Announce Second Quarter 2019 Financial Results on August 7, 2019
31/07/2019 -
Pluristem and U.S. Department of Defense Present Positive Data from Studies Testing PLX-R18 as a Prophylactic Treatment for Acute Radiation Syndrome
31/07/2019 -
Zynerba Pharmaceuticals to Present at Two Upcoming Conferences
31/07/2019 -
Selecta Biosciences to Present at Canaccord Genuity’s 39th Annual Growth Conference on August 7, 2019
31/07/2019 -
CB2 Insights Adds Former Johnson & Johnson Executive as Director
31/07/2019 -
Kaleido Biosciences to Present at the 39th Annual Canaccord Genuity Growth Conference
31/07/2019 -
Tauriga Sciences Inc. to Integrate QR Codes into Future Product Package Design(s)
31/07/2019 -
Strongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update
31/07/2019 -
Harrow Health Announces Launch of Mayfield Pharmaceuticals
31/07/2019 -
Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions
31/07/2019 -
Vaccinex Announces $13.8 Million Private Placement
31/07/2019 -
Aravive Reports Preliminary Results of AVB-500 from the First Cohort of the Phase 1b/Phase 2 Recurrent Platinum Resistant Ovarian Cancer Trial
31/07/2019 -
Clearside Biomedical Announces Multiple Oral Presentations Delivered at the American Society of Retinal Specialists (ASRS) Annual Meeting
31/07/2019
Pages